Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY98-7196 in symptomatic endometriosis
NCT02203331Phase 2Completed
- Sponsor
- Bayer
- Start
- Oct 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 14
01
Overview
Phase 2, randomised, double-blind trial in endometriosis (6 arms), sponsored by Bayer. Primary endpoint: Absolute Change in Mean Pain of the 7 Days With Worst EAPP From Baseline to End of Treatment at 12 weeks. Started Oct 2014; status: completed.
02
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02203331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203331.